Spaces:
Running
Running
Update app.py
Browse files
app.py
CHANGED
@@ -231,15 +231,16 @@ with gr.Blocks(theme=gr.themes.Soft(primary_hue="teal", secondary_hue="slate", n
|
|
231 |
|
232 |
# Add example prompts - removed file upload examples. Kept text focused examples.
|
233 |
example_prompts = [
|
234 |
-
|
235 |
-
["μμΈ νμ΄λ¨Έλ³μ λ³νμ리νμ κΈ°μ μ μ€λͺ
νκ³ , νμ¬ μ¬μ©λλ μ½λ¬Όλ€μ΄ μμ©νλ μ£Όμ νκ²μ μμΈν κΈ°μ νμμμ€. νΉν, μμΈνΈμ½λ¦°μμ€ν
λΌμ μ΅μ μ μ NMDA μμ©μ²΄ κΈΈνμ μ μμ© λ°©μκ³Ό μμμ μμλ₯Ό λΉκ΅ λΆμν΄ μ£Όμμμ€."],
|
236 |
["λ§μ± μ μ₯ μ§ν νμμμ λΉν μΉλ£λ₯Ό μν΄ μ¬μ©νλ μ리μ€λ‘ν¬μ΄μν΄ μ μ μ μ½λνμ λ° μ½λ ₯νμ νΉμ±μ μμΈν λΆμνκ³ , ν¬μ¬ μ©λ λ° ν¬μ¬ κ°κ²© κ²°μ μ μν₯μ λ―ΈμΉλ μμΈλ€μ μ€λͺ
ν΄ μ£Όμμμ€.",""],
|
237 |
["κ°κ²½λ³ νμμμ μ½λ¬Ό λμ¬μ λ³νλ₯Ό μ€λͺ
νκ³ , κ° κΈ°λ₯ μ νκ° μ½λ¬Ό ν¬μ¬λ μ‘°μ μ λ―ΈμΉλ μν₯μ ꡬ체μ μΈ μ½λ¬Ό μμμ ν¨κ» λ
Όμν΄ μ£Όμμμ€. νΉν, κ° λμ¬ ν¨μμ νμ± λ³νμ κ·Έ μμμ μ€μμ±μ μ€λͺ
ν΄ μ£Όμμμ€."],
|
238 |
["μμΈ νμ΄λ¨Έλ³ μΉλ£μ ν¨κ³Όμ μΈ μ²μ° μλ¬Ό λ¬Όμ§κ³Ό μ½λ¦¬κΈ°μ λ±μ νλ°©(νμν)μ κ΄μ μμ μ€λͺ
νκ³ μλ €μ€"],
|
239 |
["κ³ νμ μΉλ£ λ° μ¦μ μνμ ν¨κ³Όμ μΈ μ μ½ κ°λ°μ μν΄ κ°λ₯μ±μ΄ λ§€μ° λμ μ²μ° μλ¬Ό λ¬Όμ§κ³Ό μ½λ¦¬κΈ°μ λ±μ νλ°©(νμν)μ κ΄μ μμ μ€λͺ
νκ³ μλ €μ€"],
|
240 |
["Compare and contrast the mechanisms of action of ACE inhibitors and ARBs in managing hypertension, considering their effects on the renin-angiotensin-aldosterone system."],
|
241 |
["Describe the pathophysiology of type 2 diabetes and explain how metformin achieves its glucose-lowering effects, including any key considerations for patients with renal impairment."],
|
242 |
-
|
|
|
|
|
243 |
]
|
244 |
|
245 |
gr.Examples(
|
|
|
231 |
|
232 |
# Add example prompts - removed file upload examples. Kept text focused examples.
|
233 |
example_prompts = [
|
234 |
+
["Explain the interplay between CYP450 enzymes and drug metabolism, specifically focusing on how enzyme induction or inhibition might affect the therapeutic efficacy of a drug such as warfarin."],
|
|
|
235 |
["λ§μ± μ μ₯ μ§ν νμμμ λΉν μΉλ£λ₯Ό μν΄ μ¬μ©νλ μ리μ€λ‘ν¬μ΄μν΄ μ μ μ μ½λνμ λ° μ½λ ₯νμ νΉμ±μ μμΈν λΆμνκ³ , ν¬μ¬ μ©λ λ° ν¬μ¬ κ°κ²© κ²°μ μ μν₯μ λ―ΈμΉλ μμΈλ€μ μ€λͺ
ν΄ μ£Όμμμ€.",""],
|
236 |
["κ°κ²½λ³ νμμμ μ½λ¬Ό λμ¬μ λ³νλ₯Ό μ€λͺ
νκ³ , κ° κΈ°λ₯ μ νκ° μ½λ¬Ό ν¬μ¬λ μ‘°μ μ λ―ΈμΉλ μν₯μ ꡬ체μ μΈ μ½λ¬Ό μμμ ν¨κ» λ
Όμν΄ μ£Όμμμ€. νΉν, κ° λμ¬ ν¨μμ νμ± λ³νμ κ·Έ μμμ μ€μμ±μ μ€λͺ
ν΄ μ£Όμμμ€."],
|
237 |
["μμΈ νμ΄λ¨Έλ³ μΉλ£μ ν¨κ³Όμ μΈ μ²μ° μλ¬Ό λ¬Όμ§κ³Ό μ½λ¦¬κΈ°μ λ±μ νλ°©(νμν)μ κ΄μ μμ μ€λͺ
νκ³ μλ €μ€"],
|
238 |
["κ³ νμ μΉλ£ λ° μ¦μ μνμ ν¨κ³Όμ μΈ μ μ½ κ°λ°μ μν΄ κ°λ₯μ±μ΄ λ§€μ° λμ μ²μ° μλ¬Ό λ¬Όμ§κ³Ό μ½λ¦¬κΈ°μ λ±μ νλ°©(νμν)μ κ΄μ μμ μ€λͺ
νκ³ μλ €μ€"],
|
239 |
["Compare and contrast the mechanisms of action of ACE inhibitors and ARBs in managing hypertension, considering their effects on the renin-angiotensin-aldosterone system."],
|
240 |
["Describe the pathophysiology of type 2 diabetes and explain how metformin achieves its glucose-lowering effects, including any key considerations for patients with renal impairment."],
|
241 |
+
["Please discuss the mechanism of action and clinical significance of beta-blockers in the treatment of heart failure, with reference to specific beta-receptor subtypes and their effects on the cardiovascular system."],
|
242 |
+
["μμΈ νμ΄λ¨Έλ³μ λ³νμ리νμ κΈ°μ μ μ€λͺ
νκ³ , νμ¬ μ¬μ©λλ μ½λ¬Όλ€μ΄ μμ©νλ μ£Όμ νκ²μ μμΈν κΈ°μ νμμμ€. νΉν, μμΈνΈμ½λ¦°μμ€ν
λΌμ μ΅μ μ μ NMDA μμ©μ²΄ κΈΈνμ μ μμ© λ°©μκ³Ό μμμ μμλ₯Ό λΉκ΅ λΆμν΄ μ£Όμμμ€."]
|
243 |
+
|
244 |
]
|
245 |
|
246 |
gr.Examples(
|